TradeLink Capital’s Halozyme HALO Stock Holding History

TradeLink Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6,700	Closed	-$65K	–	229
2014 Q4	$65K	Buy	+6,700	New	+$59.5K	0.09%	315

Other funds holding HALO

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TradeLink Capital's HALO Position: Q1 2015 in Review

TradeLink Capital sold out of Halozyme (HALO) in Q1 2015, closing a stake of 6,700 shares — an estimated $65K sold.

TradeLink Capital first reported a position in HALO in Q4 2014 and held it in 1 quarter. The position peaked at $65K in Q4 2014. 137 funds tracked by Wall St. Rank hold HALO as of Q1 2015.

TradeLink Capital reported no remaining Halozyme position as of Q1 2015 after selling out during the quarter.
TradeLink Capital sold 6,700 Halozyme shares in Q1 2015, an estimated $65K.
TradeLink Capital first reported a position in Halozyme in Q4 2014 and held it in 1 quarter.
TradeLink Capital's Halozyme position peaked at $65K in Q4 2014.
137 funds tracked by Wall St. Rank held Halozyme as of Q1 2015.

Based on TradeLink Capital's 13F filing for Q1 2015, filed 12 May 2015.